ISIS PHARMACEUTICALS INC's ticker is ISIS and the CUSIP is 464330109. A total of 321 filers reported holding ISIS PHARMACEUTICALS INC in Q3 2015. The put-call ratio across all filers is 1.66 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2015 | $269,000 | -29.8% | 6,660 | 0.0% | 0.01% | -25.0% |
| Q2 2015 | $383,000 | -11.3% | 6,660 | -1.9% | 0.02% | -15.8% |
| Q1 2015 | $432,000 | -46.3% | 6,790 | -47.9% | 0.02% | -45.7% |
| Q4 2014 | $805,000 | +59.1% | 13,040 | 0.0% | 0.04% | +59.1% |
| Q3 2014 | $506,000 | +12.7% | 13,040 | 0.0% | 0.02% | +10.0% |
| Q2 2014 | $449,000 | -36.6% | 13,040 | -6.1% | 0.02% | -39.4% |
| Q1 2014 | $708,000 | +28.0% | 13,890 | 0.0% | 0.03% | +26.9% |
| Q4 2013 | $553,000 | +6.1% | 13,890 | 0.0% | 0.03% | -3.7% |
| Q3 2013 | $521,000 | -11.4% | 13,890 | -36.5% | 0.03% | -15.6% |
| Q2 2013 | $588,000 | – | 21,880 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BB BIOTECH AG | 6,634,838 | $268,180,000 | 8.50% |
| DOWLING & YAHNKE LLC | 676,379 | $27,339,000 | 3.72% |
| WILLIAM HARRIS INVESTORS INC | 317,301 | $12,826,000 | 3.63% |
| Opus Point Partners Management, LLC | 101,401 | $4,099,000 | 2.26% |
| SOUND ENERGY PARTNERS, INC. | 25,000 | $1,011,000 | 2.04% |
| Sonora Investment Management, LLC | 127,104 | $6,622,000 | 2.00% |
| PINNACLE ASSOCIATES LTD | 1,778,325 | $71,880,000 | 1.59% |
| MESSNER & SMITH THEME VALUE INVESTMENT MANAGEMENT LTD /CA/ | 17,000 | $687,000 | 1.36% |
| Apex Capital Management | 1,019,618 | $41,213,000 | 0.93% |
| PERKINS CAPITAL MANAGEMENT INC | 20,350 | $823,000 | 0.92% |